Cargando…
Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
Erythropoiesis usually fails during severe illness because of a blunting of the kidney–erythropoietin (EPO)–bone marrow axis. In this setting, clinical studies have shown that recombinant human erythropoietin (rhEPO), administered in pharmacological amounts, significantly reduces the need for blood...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065012/ https://www.ncbi.nlm.nih.gov/pubmed/15469595 http://dx.doi.org/10.1186/cc2897 |